Search

everythinglearnresearchcommunity

for

Search:↓

Mouse hair follicle cells briefly grow during the early hair growth phase, showing that these cells are important for starting the hair cycle.

Manipulating the catagen and telogen phases of hair growth could lead to treatments for hair disorders.

Mast cell and nerve fiber interactions in mouse skin change with the hair cycle.

The document concludes that the hair cycle is a complex process involving growth, regression, and rest phases, regulated by various molecular signals.

Vitamin D receptors in hair follicles change with the hair cycle, affecting hair growth.

Estrogen receptors affect hair growth, with ER beta slowing down the hair cycle changes caused by ER alpha.

Melanocyte activity in hair follicles is linked to the hair growth cycle, being active in growth phases and inactive in rest phases.

The conclusion is that Fgf18 and Tgf-ß signaling could be targeted for hair loss treatments.

The model accurately simulates human hair growth and hair loss patterns.

Notch signaling is essential for healthy skin and hair follicle maintenance.

The conclusion is that treatments for Telogen Effluvium exist, but standard treatment guidelines are needed.

Steroid hormone binding in rat skin varies with pH, heat, and hair cycle phases.

Hair growth slows and shedding increases after childbirth, but most women don't experience excessive hair loss.

Leptin from skin fat can slow hair growth during certain phases.

Diagnosing hair loss disorders needs clinical, dermoscopic, and histological differences, and checking menstrual cycle, weight changes, drug therapy, and nail changes.

Proteolytic activity in mouse skin changes with hair cycle stages, peaking in early anagen.

Certain genes are linked to wool follicle structure and function, but not hair cycle regulation.

Nuclear Factor I-C is important for controlling hair growth by affecting the TGF-β1 pathway.

CD10 and CD34 levels change during hair development and different hair growth stages, which could be important for hair regeneration treatments.

Etretinate therapy can cause hair loss by disrupting the hair growth cycle.

The document concludes that we need more research to understand Telogen Effluvium and find effective treatments.

NF-κB is crucial for different stages and types of hair growth in mice.

The model showed that randomness accurately describes individual hair growth cycles and that synchronization can cause large fluctuations not seen in humans.

MMP-2 and MMP-9 help hair grow, while their inhibitors peak when hair growth slows.

Increasing Wnt5a in mice skin delays hair growth but doesn't stop it.

Telogen Effluvium is a condition causing excessive hair loss due to stress, illness, drugs, or hormonal changes, and can be treated with specific products or naturally resolves after 3-4 years.

The osteopontin gene is active in a specific part of rat hair follicles during a certain hair growth phase and might affect hair cycle and diseases.

CD1d expression in scalp skin and hair follicles changes with the hair cycle and may help protect against microbes.

Androgens may worsen a natural hair resting phase, possibly leading to hair loss.

Collagen remodeling is more active during hair growth stages.